SOCO® Group ("SOCO®" or "the Company"), a technology-driven manufacturer specializing in water absorbing and retaining solutions for agricultural and industrial applications, will showcase...

Data highlights efficacy and safety of risankizumab in psoriatic disease, including high impact areas in psoriasis and long-term treatment of psoriatic arthritis Data includes real-world evidence...

As global economies evolve and expectations for healthier, greener and more people-centred environments continue to rise, office and commercial spaces are entering a new phase of transformation....

Groundbreaking new research from OLAY expands the science of skin aging beyond collagen — revealing how strengthening cellular connections can visibly improve firmness, texture and radiance DENVER,

In the ADlong Phase 3b study, nearly all EBGLYSS-treated patients achieved meaningful skin improvement (EASI-75) for up to four years 75% of patients achieved a high bar of near-complete skin...